Original Research (original) (raw)

JCP

Cardiovascular Risk Factors and Second Generation Antipsychotics

Original Research

Cardiovascular Risk Factors and Second Generation Antipsychotics

January 8, 2025

Despite well-documented cardiovascular disease (CVD) morbidity and mortality, CVD risks among people with severe mental illness who use antipsychotics are common and frequently untreated.

Virginie-Anne Chouinard, Mary Price, Sophie Forte, et al

JCP

IV Hydroxyzine vs Haloperidol for Delirium

Original Research

IV Hydroxyzine vs Haloperidol for Delirium

January 6, 2025

Hydroxyzine showed a significantly higher rate of delirium improvement than haloperidol, with no significant difference in the time to improvement.

Kaoruhiko Kubo, Moe Takehara, Mayuko Hirata, et al

JCP

Olanzapine/Samidorphan Effects on Weight Gain

Original Research

Olanzapine/Samidorphan Effects on Weight Gain

January 2, 2025

Treatment with a combination of olanzapine and samidorphan was associated with less weight gain and reduced risk of reaching ≥7% or ≥10% gain in body weight versus olanzapine over...

Christoph U. Correll, Michael J. Doane, David McDonnell, et al

JCP

Substance and Opioid Use Disorders Among IBD Hospitalizations

Original Research

Substance and Opioid Use Disorders Among IBD Hospitalizations

January 2, 2025

A higher prevalence of SUD and opioid use disorder was found among hospitalizations for inflammatory bowel disease, and these elevated prevalences were linked to distinct demographic, socioeconomic, and geographic...

Jin S. Kim, Patrick W. Chang, Jason Hung, et al

JCP

Treatments and Treatment Predictors in Patients With SUDs and ADHD

Original Research

Treatments and Treatment Predictors in Patients With SUDs and ADHD

December 23, 2024

Treatment site explained more of the variation in ADHD treatment provision than patient factors. Higher ADHD symptom severity and sobriety at intake were associated with receiving ADHD treatment.

Christoffer Brynte, Arnt Schellekens, Csaba Barta, et al

PCC

Evolution of Treatment Modalities for PTSD

Original Research

Evolution of Treatment Modalities for PTSD

December 12, 2024

The authors provide a bibliometric analysis of the most-cited articles published from 1990 to 2020 on evidence-based treatment modalities for PTSD to highlight significant developments in its understanding and management.

Mohsan Ali, Bisal Naseer, Muhammad T. Siddal, et al

JCP

Long-Term Safety and Treatment Effect of Olanzapine/Samidorphan

Original Research

Long-Term Safety and Treatment Effect of Olanzapine/Samidorphan

December 4, 2024

During up to 4 years of treatment, the combination of olanzapine/samidorphan was safe and well-tolerated, and patients’ symptoms remained stable.

Jacob S. Ballon, René S. Kahn, Christina Arevalo, et al

JCP

Sex Differences in Antidepressant Acceptability

Original Research

Sex Differences in Antidepressant Acceptability

December 4, 2024

This study provides evidence of sex differences in antidepressant acceptability, with fluoxetine more acceptable for men than women and the reverse true for paroxetine. Findings suggest the importance of...

Charles Ouazana Vedrines, Nicolas Hoertel, Thomas Lesuffleur, et al

PCC

Intervention to Enhance Mental Health Competency

Original Research

Intervention to Enhance Mental Health Competency

December 3, 2024

This study evaluated a novel curriculum aimed to increase non-psychiatry providers’ confidence in treating mental health conditions.

Maxwell F. Lydiatt, William M. Lydiatt, John C. Mitchell II, et al

JCP

PTSD and Risk of Suicide Reattempt

Original Research

PTSD and Risk of Suicide Reattempt

November 25, 2024

After controlling for comorbid psychiatric conditions and other variables, PTSD was associated with suicide reattempt at 6 months (OR= 2.33) and with rehospitalization in psychiatric settings (OR=2.24) and nonpsychiatric...

Alice Demesmaeker, Fabien D’Hondt, Ali Amad, et al

JCP

MDD and Bipolar Disorder in Black and White Postpartum Women

Original Research

MDD and Bipolar Disorder in Black and White Postpartum Women

November 20, 2024

No significant difference was observed in the rate of postpartum MDD in Black (40%) versus white (35%) women. However, bipolar disorder significantly differed between Black (19.2%) and white (11.5%)...

Taylor N. Burchfield, Amy Yang, Katherine L. Wisner, et al

JCP

Hyperbaric Oxygen Therapy for Combat-Associated PTSD

Original Research

Hyperbaric Oxygen Therapy for Combat-Associated PTSD

November 10, 2024

Hyperbaric oxygen therapy demonstrated significant improvements on measures of depression in male veterans with combat-associated PTSD.

Keren Doenyas-Barak, Ilan Kutz, Erez Lang, et al

PCC

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Original Research

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

November 7, 2024

PCOS symptoms extend beyond reproductive issues, with noted correlations to anxiety, depression, and suicidal attempts. This study assessed psychiatric comorbidities among hospitalized adolescent females with PCOS.

Chintan Trivedi, Abid Rizvi, Sahar Ashraf, et al

JCP

Mixed Features and Suicide Risk in Individuals With Major Depressive Episode

Original Research

Mixed Features and Suicide Risk in Individuals With Major Depressive Episode

November 6, 2024

In a large sample of the French population, mixed features were linked to a higher risk of suicide attempts in patients with a major depressive episode.

Hugo Peyre, Nicolas Hoertel, Baptiste Pignon, et al

JCP

History of Concussion and Maternal Mental Illness Risk

Original Research

History of Concussion and Maternal Mental Illness Risk

November 4, 2024

Individuals with a history of concussion had an increased risk of severe maternal mental illness; the association was strongest in those with no history of mental illness.

Samantha Krueger, Simone N. Vigod, Vincy Chan, et al

JCP

Opioid Use Disorder Treatment in Sexually and Gender Diverse Patients

Original Research

Opioid Use Disorder Treatment in Sexually and Gender Diverse Patients

October 30, 2024

The disparities in buprenorphine prescriptions and in outpatient medical visit access between sexually and gender diverse (SGD) and non-SGD cohorts found in this study highlight priorities for culturally responsive...

Michal J. McDowell, Amitai S. Miller, Dana S. King, et al

JCP

Suicide Crisis Syndrome Assessment and ED Readmission

Original Research

Suicide Crisis Syndrome Assessment and ED Readmission

October 23, 2024

Diagnosis of suicide crisis syndrome reduced readmission risk by approximately 72% for any reason and almost 75% for suicidal presentations.

Lisa J. Cohen, Betsy J. White, Fred E. Miller, et al

JCP

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Original Research

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

October 23, 2024

Subthreshold PTSD affects 3.5% of US military veterans and is associated with increased rates of psychiatric disorders, suicidal thoughts and behaviors, and functional difficulties.

Ian C. Fischer, Peter J. Na, Ilan Harpaz-Rotem, et al

JCP

Symptomatic Remission and Overall Recovery From BPD

Original Research

Symptomatic Remission and Overall Recovery From BPD

October 23, 2024

Over 24 years, patients with BPD were significantly slower to achieve remission or recovery than patients with other personality disorders. Ultimately, however, both groups achieved similarly high rates of...

Mary C. Zanarini, Frances R. Frankenburg, Katherine E. Hein, et al

PCC

Psychological Resilience of Mental Health Workers During the Russia-Ukraine War

Original Research

Psychological Resilience of Mental Health Workers During the Russia-Ukraine War

October 22, 2024

Interventions that bolster social connectedness, meaning in life, and optimism may help promote psychological resilience among mental health workers exposed to ongoing war-related and work-related stressors.

Hun Kang, Ian C. Fischer, Viktor Vus, et al

JCP

Gepirone-ER and Sexual Function in Patients with MDD

Original Research

Gepirone-ER and Sexual Function in Patients with MDD

October 21, 2024

Rates of sexual side effects and treatment-emergent sexual dysfunction with gepirone-ER were similar to placebo and lower than sexual side effects reported for SSRIs.

Tierney K. Lorenz, Mary F. Johnson, Anita H. Clayton

JCP

Fluctuating ADHD in the Multimodal Treatment of ADHD (MTA) Study

Original Research

Fluctuating ADHD in the Multimodal Treatment of ADHD (MTA) Study

October 16, 2024

This study demonstrates that ADHD fluctuations are common and substantive and that, when remitted, individuals with fluctuating ADHD can successfully manage increased responsibilities.

Margaret H. Sibley, Traci M. Kennedy, James M. Swanson, et al

JCP

Ketamine/Esketamine in Bipolar Depression in a Clinical Setting

Original Research

Ketamine/Esketamine in Bipolar Depression in a Clinical Setting

October 2, 2024

In a small sample of patients with bipolar depression treated with ketamine/esketamine, no evidence of mania or hypomania was seen during acute treatment.

Mia C. Santucci, Mina Ansari, Sina Nikayin, et al

JCP

Suicide Risk Evaluation and Advanced AI Models

Original Research

Suicide Risk Evaluation and Advanced AI Models

October 2, 2024

This study explored how ChatGPT-3.5 and ChatGPT-4 assess suicide risk factors like previous attempts, gender, and age, focusing on their predictions about different types of suicidal behavior.

Shiri Shinan-Altman, Zohar Elyoseph, Inbar Levkovich

1 2 3159 »